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Abstract
Background: Studies in animal models and in cultured cells have shown that fatty acids can induce alterations in the DNA
methylation of specific genes. There have been no studies of the effects of fatty acid supplementation on the epigenetic
regulation of genes in adult humans.
Methods and Results: We investigated the effect of supplementing renal patients with 4 g daily of either n-3 long-chain
polyunsaturated fatty acids (n-3 LCPUFA) or olive oil (OO) for 8 weeks on the methylation status of individual CpG loci in the
59 regulatory region of genes involved in PUFA biosynthesis in peripheral blood mononuclear cells from men and women
(aged 53 to 63 years). OO and n-3 LCPUFA each altered (.10% difference in methylation) 2/22 fatty acid desaturase (FADS)-
2 CpGs, while n-3 LCPUFA, but not OO, altered (.10%) 1/12 ELOVL5 CpGs in men. OO altered (.6%) 8/22 FADS2 CpGs and
(.3%) 3/12 elongase (ELOVL)-5 CpGs, while n-3 LCPUFA altered (.5%) 3/22 FADS2 CpGs and 2/12 (.3%) ELOVL5 CpGs in
women. FADS1 or ELOVL2 methylation was unchanged. The n-3 PUFA supplementation findings were replicated in blood
DNA from healthy adults (aged 23 to 30 years). The methylation status of the altered CpGs in FADS2 and ELOVL5 was
associated negatively with the level of their transcripts.
Conclusions: These findings show that modest fatty acid supplementation can induce altered methylation of specific CpG
loci in adult humans, contingent on the nature of the supplement and on sex. This has implications for understanding the
effect of fatty acids on PUFA metabolism and cell function.
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Introduction
Epigenetics refers to a group of heterogeneous, but interrelated
processes that regulate transcription without changing the DNA
nucleotide sequence. Specifically, epigenetics involves methylation
at the 59 position of cytosine bases in CpG dinucleotide pairs,
covalent modifications of histones, or the activities of non-coding
RNA species [1]. Although the DNA methylation of some gene
promoters, for example those involved in cell differentiation or
imprinting, is induced in early life and persists throughout the life
course, other DNA methylation marks appear to be more plastic
[2], particularly during periods of rapid growth [3]. Altered
epigenetic regulation by DNA methylation of specific genes has
been implicated as a causal factor in a number of non-
communicable diseases [4,5]. Genes that retain epigenetic
plasticity may respond to environmental inputs, including
nutrition, and so may alter gene and cell function. Thus
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understanding the impact of nutrient intakes on the epigenome has
important implications for dietary choices in relation to health.
Dietary fat intake can modify capacity for polyunsaturated fatty
acid (PUFA) by changing the mRNA expression of D6 (D6d) and
D5 (D5d) desaturases [6,7]. Although product inhibition is likely to
be involved, the underlying mechanism has not been well-
described. Changes in dietary fatty acid intake can alter the
activity of the PUFA biosynthesis pathway in rodent models via
changes in the epigenetic regulation of key genes. Increasing
dietary a-linolenic acid content during pregnancy and lactation in
mice increased the average methylation of the fatty acid desaturase
(Fads)-2, which encodes D6d, promoter and of intron 1 by up to
2% in the liver of dams [8,9]. Feeding pregnant rats diets
containing different amounts of saturated or n-3 long-chain
polyunsaturated fatty acids (n-3 LCPUFA) induced hypermethyla-
tion of specific CpG loci in the Fads2 promoter and decreased
mRNA expression in the liver of the adult offspring. This was
accompanied by decreased proportions of docosahexaenoic acid
(DHA) and arachidonic acid in membrane and plasma phospho-
lipids [10]. Feeding adult female rats a fish oil-enriched diet for 9
weeks also induced lower Fads2 mRNA expression and increased
methylation of specific CpG loci in the Fads2 promoter [10].
These changes were reversed when the animals were switched to a
soybean oil-base diet [10]. Feeding dams either 7% and 21% (w/
w) safflower oil, hydrogenated soybean oil, butter or fish oil
induced increased methylation of specific CpG loci in the Fads2
promoter and decreased its expression in aortae in the adult
offspring [11]. Mutation of one CpG locus that was hypermethy-
lated in both the liver and aortae of these offspring, which is
located within an estrogen receptor response element, decreased
the activity of the Fads2 promoter [11]. This indicates that at least
some of the hypermethylated loci were involved directly in the
regulation of Fads2 transcription. Together, these findings support
the suggestion that variation in the fatty acid supply during
development can induce persistent changes in the epigenetic
regulation of LCPUFA biosynthesis.
To our knowledge, no study has examined the effects of dietary
fatty acid intake on the epigenetic regulation of genes involved in
PUFA metabolism in adult humans. In this study, we tested the
hypothesis that dietary supplementation with preparations con-
taining either predominately n-9 monounsaturated fatty acids
(olive oil; OO) or n-3 LCPUFA induces differential changes in the
DNA methylation of genes involved in LCPUFA biosynthesis. We
measured methylation status of individual CpG loci in the 59
regulatory region of FADS2, FADS1 (which encodes D5d) and
elongase (ELOVL)-5 and ELOVL2 (which encode elongase 5 and
elongase 2, respectively) in DNA extracted from peripheral blood
mononuclear cells (PBMCs) isolated from patients with chronic
renal disease. We also tested whether any induced changes in
DNA methylation were related to the level of mRNA and whether
any effects of n-3 LCPUFA on the DNA methylation of genes
involved in LCPUFA biosynthesis could be replicated in blood
from healthy adults.
Subjects and Methods
Ethical statement
The studies were conducted according to the principles
expressed in the Declaration of Helsinki. Study 1 was approved
by the Royal Perth Hospital Ethics Committee (EC2004/045) and
is registered on the Australian Clinical Trials Register
(ACTRN012605555588640). Subjects gave informed, written
consent. Study 2 received ethical approval from the National
Research Ethics Service Committee, South Central – Berkshire
(REC reference number 11/SC/0384). Participants provided
informed, written consent.
Dietary intervention trials and sample collection
The samples used in this study were derived from specimens
collected in two dietary intervention studies, one in patients with
chronic kidney disease at the University of Western Australia
Table 1. Subject characteristics at baseline.
Male Female
Study 1 cohort
Treatment n-3 LCPUFA OO n-3 LCPUFA OO
n 8 8 6 7
Age (years) 5564 6163 5366 5564
BMI (kg/m2) 25.761.0 27.261.4 28.762.6 29.562.8
eGRF (ml/min/1.73 m2) 37.664.0 34.962.4 36.564.0 32.763.9
Cholesterol (mmol/l) 5.160.2 4.660.2 4.860.4 4.760.2
Triglyceride (mmol/l) 2.460.3 1.760.2 1.160.1 1.860.5
Creatinine (mmol/l) 209622 192616 151615 163617
Glucose (mmol/l) 5.060.2 5.060.2 4.560.3 5.160.3
HOMA-IR 3.060.4 2.460.3 2.360.8 3.261.0
Study 2 cohort
n 8 12
Age (years) 2361 3064
BMI (kg/m2) 22.660.5 21.560.5
Values are mean6 SEM. n-3 LCPUFA, fish oil; OO, olive oil; BMI, body mass index; eGRF, estimated glomerular filtration rate; HOMA-IR, homeostatic model assessment of
insulin resistance. Comparisons within male and female subjects by Student’s unpaired t test showed no significant differences (P.0.05) between treatment groups.
doi:10.1371/journal.pone.0109896.t001
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(Perth, Australia) (Study 1) and the other in healthy adults at the
University of Southampton (Southampton, UK) (Study 2).
The design of the dietary intervention trial in Study 1 has been
described in detail elsewhere [12]. The samples used in the current
study were from a sub-group of 29 men and women for whom
paired before and end of intervention samples were available, who
were non-smokers and non-diabetic, with moderate to severe
chronic renal impairment (estimated glomerular filtration rate
between 15 and 60 ml/min/1.73 m2 (normal range$90 ml/min/
1.73 m2) and serum creatinine less than 350 mmol/l (normal range
53 to 115 mmol/l). The primary exclusion criteria were use of non-
steroidal anti-inflammatory or immunosuppressive medication,
consumption of fish oil supplements, consumption of more than
one portion of fish per week or consumption of more than 4
alcoholic drinks per day. Six out of the total cohort of 35 subjects
only had single samples and so were excluded from the present
analysis. The details of the subjects from whom samples were
analysed in the current study are summarised in Table 1.
Subjects consumed 4 g n-3 LCPUFA, eicosapenatenoic acid
(EPA; 1.8 g), dosocapentaenoic acid (DPA; 0.2 g) and DHA (1.5 g)
ethyl esters in four 1 g capsules (Omacor, Solvay Pharmaceuticals,
Pymble, NSW, Australia) or 4 g olive oil (OO) in four 1 g capsules
(Cardinal Health Australia, Braeside, Victoria, Australia) each day
for 8 weeks. The study had a randomised double blind design.
Venous blood samples were collected in the fasting state and
differential blood counts were determined as described [12].
PBMCs were isolated as described [13], stored at 280uC,
transported for analysis on dry ice and stored at 280uC until
analysed.
The subjects for comparator analyses in Study 2 were the health
subjects in a reference group in a study that compared the effect of
fish oil supplementation in individuals who were of normal BMI or
Figure 1. Sequences of the 59 regions of (A) FADS2, (B) FADS1, (C) ELOVL5 and (D) ELOVL2 that were analysed by pyrosequencing.
Individual CpG loci are indicated by their position relative to the transcription start site (bp) and are underlined. Sequences corresponding to CpG
islands are indicated grey shading.
doi:10.1371/journal.pone.0109896.g001
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clinically obese. Subjects men and women of BMI between 18.5
and 25 kg/m2, with fasting plasma glucose ,5 mmol/l, triacyl-
glycerol ,1.0 mmol/l and total cholesterol less than 5 mmol/l
who did not consume fish oil or other oil supplements, who did not
eat more than one oily fish meal per week, did not have diagnosed
diabetes or chronic gastrointestinal problems and were not
pregnant or planning to become pregnant within the study period.
Subjects were excluded if they used prescribed medicine to control
inflammation, to control blood lipids or to control blood pressure.
The characteristics of the subjects in Study 2 are detailed in
Table 1. A fasting venous blood sample was collected at baseline
and an aliquot of whole blood was stored at 220uC. Subjects then
received EPAX6000 TG (EPAX, Oslo, Norway) which provided
1.1 g EPA, 0.1 g DPA plus 0.8 g DHA in the form of a
triacylglycerol per day for 12 weeks. A second fasting blood sample
was collected at the end of the study and an aliquot of whole blood
stored at 220uC.
Table 2. PCR primer sequences.
Primer location
(bp relative to TSS) PCR primer sequences
Start End Forward (59 to 39) Reverse (39 to 59)
FADS1
–309 –309 GGAGGGTTAGAGTTTGGAGATT CCCCCCATAAATCTTAAACAACTCACAA
–392 –375 AGTGAATGGATTGAGGGGTTAG CCCCCACCAAAACATCCACAACCTAA
–504 –418 AGTGAATGGATTGAGGGGTTAG ACCCCCACCAAAACATCCACA
–586 –528 AGAGGTAAATAGGGTTATAAAAATTGTG CCTCCAAAATTAAAAACTACTACCTACTTA
–754 AAGAGGTAAATAGGGTTATAAAAATTGTG CCTCCAAAATTAAAAACTACTACCTACT
–830 AGGGTTTTTAGGAGTTTTTAGGTTAGAA ACAATTTTTATAACCCTATTTACCTCTTT
–905 AAGAATAGTGTTTGGTATATAGTAAGTG AACCTCTCCTAACCCTTAAATATTTCACCT
–1037 AAGAATAGTGTTTGGTATATAGTAAGTG TCTCCTAACCCTTAAATATTTCACCT
FADS2
–1661 1655 GTATGGTGGTTTTGAGGATTGTT AAAATACTCCCTAATTCTACCTTTCAACTA
–1337 TTGTTGTGAAATTTAGATTGGGTAGG CCTAAAAAAAATAAACCTAACTACAT
–1278 TTGTTGTGAAATTTAGATTGGGTAGG CCTAAAAAAAATAAACCTAACTACAT
–1156 TTGTTGTGAAATTTAGATTGGGTAGG CCTAAAAAAAATAAACCTAACTACAT
–1119 –1101 ATTTGAGGGTTTTATAATTTTTTTAGTGAT ACCCTAATCTCAATAAACTCAATCT
–1071 –1056 ATTTGAGGGTTTTATAATTTTTTTAGTGAT CCCTAATCTCAATAAACTCAATCTCTT
–1013 –975 ATTTGAGGGTTTTATAATTTTTTTAGTGAT CCTTACCCTAATCTCAATAAACTCAATC
–914 –855 GGTAGTTTTTATTTGTTGGAGTTTGTAT AAACCTCTACTCTACTTTCTTAATCT
–817 –775 ATTGAGTTTATTGAGATTAGGGTAAGG ACTTTAAACCCTCTAATCAAACAATCTT
–718 –667 ATTGTTTGATTAGAGGGTTTAAAGTT AAACTCCAATATCCCACATTAT
–258 –244 AAGATTTTTTTGGGTTAATGGT ATCCCTAACTTCCCAATACC
–133 –84 AAGATTTTTTTGGGTTAATGGT AAATCCCTAACTTCCCAATAC
–64 –50 GGGGAGTTTTTATTGGAGGTAA AATCCCTAACTTCCCAATACC
–18 TGGGGGTATTGGGAAGTTAG CCCTCCCCCAACCTTCTC
ELOVL 2
–237 –270 TTTGGGTAGAGGGTGGGTATTTT CCTCTCCCACAAAAACCT
–292 –350 AGATTGAGTAAATTTGTAGGAATAGAGT AAACCCCAAAAATACCCACC
–376 AGGAGGTTATAGTTTTGTTTATAGTGAAGA AAACCCCAAAAATACCCACC
–429 AGGAGGTTATAGTTTTGTTTATAGTGAAGA TCCACCAAACCCCAAAAATACCC
–481 –508 AGGAGGTTATAGTTTTGTTTATAGTGAAGA CACATTAAAAAAAAATAACTCTATTCCTAC
ELOVL 5
–6 –14 GGTTTATTAGGAAGAAAGGGGAAAA AACCTAAACCCAAATTAACCCC
–59 –100 GGGAGTTATGGTTATAATAGTTTTGAGT ATTTTTTTCCCCTTTCTTCCTAAT
–134 –185 AGGGAGTTATGGTTATAATAGTTTTGAGT ACCCTAAACTCTAATTTTTTTACTACCA
–231 –266 TTTTGTAAGGGAGTTATGGTTATAATAGT ACCCTAAACTCTAATTTTTTTACTACC
–269 –316 AGAGTAGAAATGGAGTTGATAGTGG ACCCTAAACTCTAATTTTTTTACTACCA
–633 –686 GGAGGTTGTAGTGAGTTGAGA AACCTTCATTAACTTTATATCCTACTATT
TSS, transcription start site.
doi:10.1371/journal.pone.0109896.t002
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Isolation of DNA and analysis of DNA methylation
Genomic DNA was isolated from 200 ml PBMC or whole blood
using the QIAmp DNA blood mini kit (Qiagen, 51106) according
to the manufacturer’s instructions. The level of methylation of
individual CpG dinucleotides in the 59 regulatory regions of FADS
1 and 2, and ELOVL 2 and 5 was measured from 2504 to 2
1037, from 218 to 21661, from 2292 to 2508 and from 26 to
2686 bases, respectively, upstream from the transcription start site
(Figure 1) using sodium bisulphite pyrosequencing essentially as
described [10]. PCR primers and pyrosequencing probes are listed
in Tables 2 and 3. Bisulphite conversion was carried out using the
EZ DNA methylation kit (ZymoResearch, D5006). Modified DNA
was amplified using KAPA2G Robust Hot Start Taq DNA
polymerase (Anachem, KK5702). PCR products were immobi-
lised on streptavidin–sepharose beads (GE Healthcare UK Ltd.,
17-5113-01), washed, denatured and released into annealing
buffer containing the sequencing primers. Pyrosequencing was
carried out using CDT reagents (Qiagen, 972824) on a PSQ
96MA machine (Qiagen, 972824). Per cent methylation at each
CpG locus was calculated using the Pyro Q CpG software
(Biotage). The within assay coefficient of variation was less than
5% for all CpG loci that were measured and the limit of detection
was 5% methylation.
Table 3. Pyrosequencing primers.
Starting location (bp relative to TSS) Primer sequence
FADS1
–260 AGTTTTGGTTTTTTAGTTTATTTA
–309 GATTGAGGGGTTAGG
–392 GGTAGGGGTTGAGGTTT
–504 AGGGTTTTTAGGTTGT
–586 AGTTTTTTTTTAATTATTATTAAGT
–754 AATATTTAAGGGTTAGGAG
–830 CTAAAACATTTCTATTCTAACCT
–905 AGTTTTGTAATTGGTAATTTTA
–1037 GGAGAATTAAATGAGTTAAGG
FADS2
–1661 TGGTTTTGAGGATTGTTAA
–1337 AGATTGGGTAGGGTT
–1278 GGTTTTTTATTTTTAAGTGAGATG
–1156 GGGTTTTATAATTTTTTTAGTGAT
–1119 AAAATAAACCTAACTACATCC
–1071 CCTCAAACCCCAACT
–1013 ATTATACAAACTCCAACAAAT
–914 ATTATTGTTTAATGATGTGTTTG
–817 CCTCTAATCAAACAATCTTAAAA
–718 AGAGGGTTTAAAGTTTTTTAAT
–258 GATTTTTTTGGGTTAATGGTA
–133 GGGTAGAGGAGGTGT
–64 CCCAATACCCCCAAA
–18 GGGAAGTTAGGGATT
ELOVL2
–237 GGGTATTTTTGGGGTT
–292 GAAGTTTAATTGTAAGTAAGAT
–376 TTATTTTTTTTTAATGTGTGTTTTA
–429 AATAACTCTATTCCTACAAATT
–481 AGAGATTTTTGTTTAGGG
–6 ELOVL 5
–59 CCTAAACCCAAATTAACCCCTC
–134 GTAAAAAAATTAGAGTTTAGGG
–231 AGTATGATATAATTTATAGAGGAGA
–269 ACTAAAAAAAATCCACTTCATC
–633 AAATTAGAATTTTTAAGAAAAATAT
TSS, transcription start site.
doi:10.1371/journal.pone.0109896.t003
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Analysis of mRNA expression
mRNA was isolated from PBMCs using Tri Reagent (Sigma,
T9429). Complementary DNA was prepared and amplified by
real-time RT PCR using SYBR Green Jumpstart Ready Mix
(Sigma, S4438) as described previously [14]. The level of mRNA
expression was quantified using commercially prepared primer
pairs for FADS1 Hs_FADS1_1_SG QuantiTect primer assay,
FADS2 (Hs_FADS2_1_SG QuantiTect primer assay), ELOVL 2
(Hs_ELOVL2_1_SG QuantiTect primer assay) (all from Qiagen).
The assay conditions were as described by the manufacturer and
were validated in house before use. ELVOL5 was quantified using
bespoke primer sets (59 to 39 TATGAAGATTATCCGTGTC; 39
to 59 TGGCACCAAAATAAGAGT) (Eurofins Genomis, http://
eurofinsgenomics.eu). Cycle parameters were 95uC for 2 minutes
then 40 cycles of 95uC for 30 s, 55uC (cyclophilin, FADS1,
FADS2, ELOVL2) or 60uC (ELOVL5) for 1 min and 72uC for
1 min. Samples were analysed in duplicate and the level of the
individual transcripts was normalised to cyclophilin (Qiagen,
Hs_PPIA_1_SG QuantiTect primer assay) by the standard curve
method [15].
Statistical analysis
There are no previous data sets of methylation levels of the
genes of interest on which to base calculations of sample size.
Therefore, retrospective analysis of statistical power was carried
out for exemplar levels of methylation of 95%, 47% and 17% in
FADS2. For these levels of methylation, 7 subjects per group
would provide a statistical power of 80% to detect a difference of
10% with a probability of P,0.05. Male and female subjects were
analyzed separately. The primary statistical analyses were as
follows. Statistical comparisons of methylation level at baseline
between male and female subjects were by Student’s unpaired t
test. Comparison of end of treatment values with baseline values
was by Student’s paired t test. The effect of treatment was
determined by ANCOVA with supplement as a fixed factor and
baseline methylation, age, BMI, proportion of lymphocytes and
neutrophils as covariates with Bonferroni’s post hoc correction.
The relationship between the level of methylation at individual
CpG loci and that of the mRNA expression of the corresponding
transcript was by Pearson’s correlation analysis.
Figure 2. Values are mean ± SEM methylation of individual CpG loci at baseline in the 59 regulatory regions of (A) FADS2, (B)
FADS1, (C) ELOVL5 and (D) ELOVL2 in PBMCs from male (open bars) and female (closed bars) subjects in the Study 1 cohort.
Numbers of subjects are listed in Table 1. Locations of individual CpG dinucleotides are relative to the transcription start site (TSS). Dotted horizontal
line indicates the analytical limit of the assay.
doi:10.1371/journal.pone.0109896.g002
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Results
Subjects
There were no significant differences by one-way ANOVA in
the characteristics of the subjects at baseline between the dietary
supplementation groups in the Study 1 cohort (Table 1). However,
the subjects in the Study 2 cohort were significantly younger (P,
0.001) and had a lower BMI (P,0.001) than the subjects in the
Study 1 cohort (Table 1). There were no significant differences in
subject characteristics between males and females in either cohort.
Methylation at baseline in the Study 1 cohort
Since the limit of detection was 5%, CpG loci that exhibited
methylation of 5% or less were regarded as essentially unmethy-
lated. This is consistent with previous reports [16]. The level of
methylation of FADS2, FADS1 and ELOVL5 tended to be related
inversely to distance from the transcription start site (TSS)
(Figure 2 A–C). While this transition was gradual for FADS2,
there appeared to be a sharp demarcation between a highly
methylated (.70%) region distal to the TSS and the proximal
region which was essentially unmethylated region in FADS1 and
ELOVL5 which is consistent with the presence of CpG islands
within the proximal promoters of FADS1 and ELOVL5
(Figure 1). Methylation of individual CpG loci in the 59 regulatory
region of ELOVL2 appeared to be essentially uniform with
methylation levels between approximately 10% to 20%, with the
exception of a CpG located at 2429 bp from the TSS (CpG 2
429) which had a markedly greater level of methylation,
approximately 80%, compared to the other CpG loci that were
measured in this gene (Figure 2D).
Effect of dietary supplementation with n-3 LCPUFA or OO
on the methylation of individual CpG loci in the Study 1
cohort
Both OO and n-3 LCPUFA induced significant changes
compared to baseline in the level of methylation of individual
CpG loci in specific genes involved in PUFA metabolism in
PBMCs in the Study 1 cohort that were contingent on sex. In
males, n-3 LCPUFA increased methylation at CpG 2806 (12.5%)
in FADS2 compared to baseline, but decreased methylation at
CpG2775 (11.8%) (Figure 3A). Supplementation with OO
increased the level of methylation compared to baseline at both
of these loci by 13% and 24.0%, respectively (Figure 3A). In
females, n-3 LCPUFA supplementation induced increased meth-
ylation of FADS2 at CpGs 21071 (8.0%), 2975 (6.2%), 2871
(4.6%) and at CpG2775 (8.9%) compared to baseline (Figure 3B).
Supplementation with OO increased methylation at CpGs 21119
(6.3%), 21101 (14.6%), 2871 (13.1%), 2869 (16.5%), 2855
(13.3%), 2817 (17.5%), 2806 (13.9%) and CpG 2775 (8.9%)
compared to baseline (Figure 3B).
In males, supplementation with n-3 LCPUFA increased the
level of methylation of CpG 2686 (10.1%) compared to baseline
in ELOVL5, but did not alter significantly the level of methylation
of the other CpGs that were measured (Figure 2E). There was no
significant effect of supplementation with OO on the methylation
of CpG loci in ELOVL5 (Figure 2E). In females, n-3 LCPUFA
supplementation increased the level of methylation of CpG 2686
(3.1%) and CpG 2269 (2.1%) in ELOVL5 compared to baseline
(Figure 3F). Supplementation with OO decreased methylation of
CpG 2686 (3.1%), but increased methylation of CpG 2269
(7.6%) and CpG 2259 (4.6%) compared to baseline (Figure 2F).
There was no significant effect of supplementation with either n-3
LCPUFA or OO on the level of methylation of any of the CpGs
measured in FADS1 or in ELOVL2 in males or females
(Figure 3C, D, G, H).
In males, the type of oil used in the dietary supplement induced
differential methylation of CpG2775 (22%) in FADS2 (Table 4) and
of CpG 2686 (11%) in ELOVL5 (Table 5). In females, supplemen-
tation induced differential methylation of CpGs21071 (8.5%),2975
(4.1%), 2871 (8.2%), 2869 (10.7%), 2855 (10.0%), 2817 (22.1%)
and 2775 (7.4%) in FADS2 (Table 4). The type of dietary oil
supplement induced differential methylation at CpG 2686 in males
(11%) and in females (6.5%) in ELOVL5 (Table 5). There were no
significant differences between the effects of the dietary supplements
on the methylation of other CpG loci in FADS2 or ELOVL5, nor in
the level of methylation of any other CpG loci measured in FADS1 or
ELOVL 2 in males or females (Tables 4 and 5).
Effect of dietary supplementation with n-3 LCPUFA on
the methylation of individual CpG loci in the Study 2
cohort
We investigated whether the changes in methylation induced by
supplementation with n-3 LCPUFA in the Study 1 cohort could be
replicated in a second cohort of health individuals. For FADS2, n-
3 LCPUFA supplementation in the Study 2 cohort also induced an
increase in methylation at CpGs 2803 and 2775 in males and in
CpGs 21071, 2975 and 2775 in females (Figure 4A) to those
induced in the UWA cohort (Figure 2 A, E). However, increased
methylation at CpG 2871 in females in the UWA cohort was not
replicated in the Study 2 cohort (Figure 4A). For ELOVL5, the level
of methylation of CpG2686 was increased compared to baseline in
both the Study 1 and Study 2 cohorts (Figure 4B). However, the
level of methylation of CpG 2269, which was increased compared
to baseline in females who received the n-3 LCPUFA supplement in
the Study 1 cohort, was unchanged in females in the Study 2 cohort.
CpGs in FADS2 or ELOVL5 that were measured in the same
amplicons as those that showed altered methylation, but which did
not exhibit a change in methylation following n-3 LCPUFA
supplementation in the Study 1 cohort, also did not show altered
methylation in the Study 2 cohort (Figure 4).
The relationship between the methylation of individual
CpG loci and the mRNA level of the corresponding
transcripts
The level of methylation of specific CpG loci in FADS2 and
ELOVL5, but not FADS1 nor ELOVL2, in the Study 1 cohort
were associated significantly the level of the mRNA transcript in
samples collected at the end of the study irrespective of subject sex
or dietary supplement. There were no significant differences in
FADS1 or ELOVL2 mRNA expression between baseline and end
of study samples (Figure 5 A, C). However, the mRNA expression
of FADS2 was reduced significantly in all dietary groups, while
Figure 3. Values are mean ± SEM difference in methylation from baseline of individual CpG loci in the 59 regulatory regions of (A,
B) FADS2, (C, D) FADS1, (E, F) ELOVL5 and (G, H) ELOVL2 in PBMCs from male (A, C, E, G) and female (B, D, F, H) subjects in the
Study 1 cohort who received n-3 LCPUFA (open bars) or OO (closed bars) supplements. Numbers of subjects are listed in Table 1.
Locations of individual CpG dinucleotides are relative to the transcription start site (TSS). *Means that were significantly different by Student’s paired t
test between baseline and end of intervention samples are indicated by aP,0.05, bP,0.01, cP,0.001, dP,0.0001.
doi:10.1371/journal.pone.0109896.g003
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ELOVL5 expression was reduced in females who received the OO
supplement and in males who received with the OO or n-3
LCPUFA supplement at the end of the study compared to baseline
(Figure 5 B, D). The CpGs at 2119, 2871, 2869, 2806 and 2
775, which showed altered methylation in response to dietary
supplementation, were associated negatively with the level of the
FADS2 transcript (Table 6). The CpGs 2686 and 2259 in
ELOVL5, which showed altered methylation in response to
dietary supplementation, were associated negatively with the level
of the ELOVL5 transcript (Table 6). These associations are
illustrated for FADS2 CpG 2775 and ELOVL 5 CpG 2686 in
Figure 6.
Figure 4. Values are mean ± SEM difference in the methylation of individual CpG loci from baseline in the 59 regulatory regions of
(A) FADS2 and (B) ELOVL5 in PBMCs from male (open bars) and female (closed bars) in the Study 1 cohort who consumed a n-3
LCPUFA supplement. Numbers of subjects are listed in Table 1. Locations of individual CpG dinucleotides are relative to the transcription start site
(TSS). *Means that were significantly different (P,0.05) by Student’s paired t test between baseline and end of intervention samples.
doi:10.1371/journal.pone.0109896.g004
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Discussion
The findings of this study show for the first time that modest
dietary supplementation with either n-9 monounsaturated fatty
acids or n-3 LCPUFA induces altered DNA methylation in specific
genes involved in LCPUFA metabolism in leukocytes from adults
that differed between the type of supplement and between sexes.
The methylation profile of CpGs within the 59 regulatory region
of the four key genes involved in LCPUFA biosynthesis has not
been reported previously in humans. FADS2 was characterised by
a gradual decline in the level of methylation of individual CpG loci
90% to 20% with decreasing distance from the transcription start
site. Previous reports in rodents have shown that the level of
methylation of the Fads2 promoter in mice was less than 10%
[8,17], while in rats the level of methylation was between 30% and
90%, increasing with distance from the transcription start site
[10,11]. This implies that the epigenetic regulation of this gene may
be more similar in humans to rats, than to mice, which may have
implications for understanding the epigenetic regulation of FADS2
in these species. However, since FADS2 appears to have multiple
TSS (http://www.ensembl.org/Homo_sapiens/Gene/Summary?
db=core;g=ENSG00000134824;r=11:61560452–61634826), de-
tailed promoter mapping in the different species would be necessary
to establish differential species-specific regulation of this gene. The
level of methylation of some CpG loci in the 59 regulatory region of
FADS2 has been reported previously in HepG2 cells [18]. Despite
prolonged passage of this hepatocellular carcinoma cell line in
culture, the methylation levels of the CpG loci that were measured
were comparable to those reported here, with the exception of CpG
21661, which had approximately 30% lower methylation in
HepG2 cells [18]. Whether this difference in methylation reflects an
effect of prolonged adaptation to in vitro culture or differences in
cell type between leukocytes and hepatocellular carcinoma cells
cannot be determined from these findings. However, together these
observations suggest that the epigenetic regulation of the FADS2
gene may be similar in the two distinct cell types and that HepG2
cells may be a suitable model of the epigenetic regulation of FADS2
in humans.
FADS1 and ELOVL5 showed a marked demarcation between
a highly methylated region distal to the transcription start site and
an essentially unmethylated proximal region. ELOVL2 showed a
similar level of methylation, about 20% across the region that was
measured with the exception of CpG 2429 that showed markedly
higher methylation. However, the role of this CpG locus in the
regulation of ELOVL2 and the effect of differential methylation of
this site on the transcription of the gene is not known.
There is substantial evidence that women have higher DHA
status [19] and capacity for DHA synthesis [20,21] than men. This
sex difference has also been shown in rodents to be accompanied
by differential mRNA expression of Fads2 and Fads1 in the liver
[22,23]. In the present study, we found no differences between
men and women in the methylation status of individual CpG loci
in any of the gene regions that were investigated. This suggests that
differential methylation of FADS1 or 2, or of ELOVL 2 or 5 may
not contribute significantly to the sex difference in DHA status.
Previous studies have shown that supplementation of pregnant
rodents with different types and amounts of dietary fats induced
hypermethylation of specific CpG loci in the Fads2, but not Fads1,
promoter in the liver and aortae of the offspring [10,11]. The
nature of such changes differed according to the type and amount
of fat in the maternal diet. Similarly, feeding adult rats a diet
enriched in fish oil induced hypermethylation of specific CpG loci
in the Fads2 promoter which was reversed by withdrawal of the
high n-3 LCPUFA diet [10]. Feeding adult male mice a high fat
diet induced hypermethylation of specific CpG loci in stearoyl-
CoA desaturase [24]. Treatment of cells in culture with EPA has
also been shown to induce altered methylation of sCCAAT/
enhancer binding protein-b [25]. To our knowledge there have
been relatively few studies of the effect of dietary fat on DNA
methylation in humans. Consuming a high fat diet for 5 days
induced altered methylation of 7,909 CpG loci in 658 genes in
Figure 5. Change in relative mRNA expression of (A) FADS1, (B)
FADS2, (C) ELOVL2 and (D) ELOVL5 in peripheral blood
mononuclear cells from Study 1. *Means at the end of the end
of the study that were significantly different (P,0.05) compared to
baseline assessed by Student’s paired t test. Combined data refers to
the overall change in mRNA expression irrespective of sex or
supplement (these data were used to test the statistical association
with the methylation status of the respective genes).
doi:10.1371/journal.pone.0109896.g005
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skeletal muscle from young men [26]. Feeding 400 mg DHA per
day to pregnant women from mid gestation to term induced a
small increase (about 1%) in the methylation status of LINE-1
sequences in leukocytes from umbilical cord blood [27]. However,
the nature of the latter study design may limit the interpretation of
these findings [28]. The current findings show that consuming
supplements enriched in n-9 monounsaturated fatty acids or n-3
LCPUFA induces differential changes in the methylation of
individual CpG loci in two out of the four genes that were
investigated. Such differential effects are consistent with previous
findings in rodents [11]. Furthermore, the pattern of induced
changes in DNA methylation differed between men and women
such that in terms of the number of CpG loci that were affected,
the effect of the dietary supplements was greater in women than in
men in both FADS2 and ELOVL5.
The effects of supplementation with n-3 LCPUFA that were
observed in the patients with chronic kidney disease were fairly
well replicated in the cohort of healthy individuals in terms of the
number and location of the CpGs that were changed in both
FADS2 and ELOVL5, and the direction of the effect on these
genes. There were two exceptions, CpG 2871 in FADS2 and
CpG 2269 in ELOVL5 showed increased methylation (approx-
imately 5%) in women in the Study 1 cohort who consumed the n-
3 LCPUFA supplement, but were unchanged in the Study 2
cohort. However, overall these findings suggest that effect of
supplementation with n-3 LCPUFA on DNA methylation of
FADS2 and ELOVL5 was not affected significantly by differences
in the fatty acid composition of the n-3 LCPUFA preparations, or
the age, BMI, health status or geographical location of the
subjects. Since the changes induced in the methylation of FADS2
and ELOVL5 were similar after either 8 or 12 weeks supplemen-
tation, these findings also suggest that the effects of increased
intakes of n-3 LCPUFA had reached a maximum response by 2
months. CpGs in FADS2 and ELOVL that were proximal to those
that showed altered methylation but were unaffected by the
dietary supplement in the Study 1 cohort, were also unaffected in
the Study 2 cohort. This confirms the specificity of the effects of
the different fatty acid supplements.
The methylation status of specific CpG loci in Fads2 has been
shown previously in rats to directly influence the level of
transcription [11]. We investigated whether the level of methyl-
ation of individual CpG loci in the four genes of interest was
associated with the level of the corresponding transcripts. We
found that the methylation status of four CpG loci in FADS2 and
one CpG loci in ELOV5, which showed induced changes in
methylation following dietary supplementation, were negatively
associated with the level of the FADS2 and ELOVL5 transcripts,
respectively. Although this does not provide a direct functional
assessment of the effect of altered methylation at these loci on the
level of transcription, such associations are consistent with
increasing DNA methylation inducing a lower level of transcrip-
tion. Increased total dietary fat intake [6,7], or supplementation
with olive oil [29] or n-3 LCPUFA [30] has been shown to
decrease the conversion of 18 carbon essential fatty acids to their
longer chain metabolites. The present findings suggest that
increased intakes of n-3 LCPUFA or olive oil may reduce PUFA
biosynthesis via changes in the epigenetic regulation of FADS2
Figure 6. Change in relative mRNA expression compared to
change in the methylation status of (A) FADS2 CpG 2775 and
(B) ELOVL5 CpG 2686 irrespective of subject sex or supple-
mentation group in peripheral blood mononuclear cells from
Study 1. The corresponding correlation efficients are shown in Table 6.
doi:10.1371/journal.pone.0109896.g006
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and ELOVL5 that affect gene transcription, possibly in addition to
any effect of product inhibition. Since olive oil is not a pure
preparation of fatty acids, it cannot be assumed that the changes in
DNA methylation were due to the lipid content of the oil since
other biologically active compounds are present such as polyphe-
nols [31]. Because D6d is the rate-limiting enzyme in PUFA
biosynthesis, lower transcription of FADS2 would tend to down-
regulate the activity of the whole pathway. However, lower
transcription of ELOVL5 may reduce conversion of dihomo-c-
linolenic acid to archidonic acid and EPA to DPAn-3. If so, one
possible consequence could be to increase the synthesis of
substrates for the synthesis of prostaglandin (PG) E1 and PGE3,
relative to PGE2.
The nature of this study design has some limitations. Although
retrospective analysis suggested that the study was adequately
powered to detect differences of 10%, changes in methylation of
less than10% need to be considered cautiously. Replication of the
study in a larger prospective cohort of healthy individuals,
preferably with a crossover rather than parallel design, would be
desirable to substantiate the current findings. It would also be
desirable to test the dietary supplements at more than one dose.
Because cell differentiation involves differential changes in the
methylation of individual genes, it is possible that variations in cell
populations may have contributed to the variation in the level of
methylation of individual CpG loci, although differences in the
proportions of individual cell populations were taken into account
in the analysis of the samples from the Study 1 cohort.
Furthermore, the similarities in the findings from the Study 2
cohort, which were based on DNA isolated from whole blood
without correction for leukocyte sub-types, to those from the Study
1 cohort supports the suggestion that variation in cell populations
does not significantly affect the methylation of these genes. Finally,
although there were significant associations between the methyl-
ation status of individual CpG loci and the level of the
corresponding mRNA transcripts, the effect of variation in DNA
methylation of these genes on their transcription and on PUFA
biosynthesis remain to be demonstrated directly.
Overall, the findings of this study show that dietary supple-
mentation of adult humans with modest amounts of n-3LCPUFA
or olive oil can induce selective changes in the methylation status
of individual CpG loci in specific genes, which is contingent on the
sex of the subject and the nature of the supplement. Such findings
may have implications for understanding the mechanisms the
underlie the health benefits associated with higher consumption of
fish oil [32,33] or olive oil [34]. Furthermore, altered DNA
methylation has been implicated as a causal process in a number
of non-communicable diseases [4,5]. One challenge in the design
of therapeutic strategies to ameliorate or reverse altered patterns of
DNA methylation in disease states is targeting the intervention to
specific CpG loci [35]. One possible implication of the current
findings is that supplementation with specific fatty acids or
combinations of fatty acids may provide a means of delivering
health benefits by inducing selective modification of the methyl-
ation status of specific CpG loci.
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